Adam Berger, MD, FACS

Adam Berger, MD, FACS

Contact Dr. Berger

1100 Walnut Street
MOB, Suite 500
Philadelphia, PA 19107

(215) 955-1622
(215) 923-8222 fax

Most Recent Peer-reviewed Publications

  1. Acquired disorders with depigmentation: A systematic approach to vitiliginoid conditions
  2. Guidance of sentinel lymph node biopsy decisions in patients with T1-T2 melanoma using gene expression profiling
  3. Patients with Non-response to Neoadjuvant Chemoradiation for Esophageal Cancer Have No Survival Advantage over Patients Undergoing Primary Esophagectomy
  4. Consecutive case series of melanoma sentinel node biopsy for Lymphoseek compared to sulfur colloids
  5. The next-generation BET inhibitor, PLX51107, delays melanoma growth in a CD8-mediated manner
  6. Role of Adjuvant Multimodality Therapy after Curative-Intent Resection of Ampullary Carcinoma
  7. Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA
  8. Correction to: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study (Annals of Surgical Oncology, (2018), 25, 9, (2541-2549), 10.1245/s10434-018-6470-1)
  9. Utility of CT imaging in a novel form of high-dose-rate intraoperative breast radiation therapy
  10. ErbB3 targeting enhances the effects of MEK inhibitor in wild-type BRAF/NRAS melanoma
  11. 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study
  12. Characterization and Optimal Management of High-risk Pancreatic Anastomoses during Pancreatoduodenectomy
  13. A standardized comparison of peri-operative complications after minimally invasive esophagectomy: Ivor Lewis versus McKeown
  14. Response and resistance to paradox-breaking BRAF inhibitor in melanomas in vivo and Ex vivo
  15. Pancreatogastrostomy Vs. Pancreatojejunostomy: a Risk-Stratified Analysis of 5316 Pancreatoduodenectomies
  16. Surgical approaches to adenocarcinoma of the gastroesophageal junction: the Siewert II conundrum
  17. Monitoring neoadjuvant chemotherapy for breast cancer by using three-dimensional subharmonic aided pressure estimation and imaging with US contrast agents: Preliminary experience
  18. Surgical Apgar score (SAS) predicts perioperative morbidity, mortality, and length of stay in patients undergoing esophagectomy at a high-volume center
  19. Comparative Quantitative Lymph Node Assessment in Localized Esophageal Cancer Patients After R0 Resection With and Without Neoadjuvant Chemoradiation Therapy
  20. VAPC-1 Targeted 64Cu-TP3805 kit preparation and its evaluation